SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

The crypto token SLAP is gaining attention due to its strong community, real-world partnerships including sponsored athletes, and recent success with Team SLAP pro MMA fighter Karolina Arm. Community members highlight it's more than just a meme, but a lifestyle, actively promoting the token's unique branding and partnerships. With mentions alongside major cryptocurrencies and growing mindshare, SLAP is capturing the attention of the crypto community.

The $ROSIE project centers around a unique, AI-powered memecoin inspired by "Rosie the Robot," a beloved character known for her role as a caring, motherly robot in popular culture. The purpose of $ROSIE is twofold: entertainment through an interactive AI feature and social impact via charitable donations.  Users can interact with an AI version of Rosie on the project’s website, where they can ask questions and engage in conversations. The utility of $ROSIE goes beyond typical memecoins by enabling users to donate tokens, which will be directed towards charitable causes supporting mothers. Through this initiative, the project combines the viral appeal of meme tokens with meaningful contributions to social causes, while leveraging AI technology to create a novel user experience.

Rosie the Robot

Rosie the Robot (ROSIE) is gaining attention, with the community highlighting its potential and bullish sentiment. The token appears to be associated with the Solana blockchain, as indicated by the ticker $SOL. Investors are anticipating future growth for this token.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending as traders discuss its recent volatility and a company statement addressing the stock's movement; the community is weighing the potential for a rebound against concerns about dilution and market manipulation. Bullish investors are encouraged by the after-hours activity and the company's position in the artificial heart market, while others remain skeptical about its long-term prospects.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is trending as traders discuss its potential for a significant run, citing its small float and high insider ownership. Community members are drawing comparisons to past high-flying stocks and anticipating a strong opening. Bullish sentiment seems to be fueled by news, with some cautioning about potential pullbacks.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid rumors of a potential sale following reports that the company's chair discussed selling for over $10 billion. Community members are debating the likelihood of a sale, potential buyers like SpaceX or Verizon, and the impact on the company's existing relationship with Apple. The discussions are also considering Globalstar's spectrum value and recent developments in the satellite IoT sector.

Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. It focuses on developing BNC210, an oral drug designed for the acute treatment of social anxiety disorder (SAD) and the chronic treatment of post-traumatic stress disorder (PTSD) by selectively targeting the a7 nicotinic acetylcholine receptor. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.

Neuphoria Therapeutics Inc.

NEUP is trending due to a surge in price and volume, potentially fueled by recent insider buying and milestone payments from Merck related to their Alzheimer's program. The community is actively discussing the stock's low float and the potential for a short squeeze, with some traders speculating about a run to double digits. However, some traders also caution about potential dilution.

Huntington Ingalls Industries, Inc. engages in the shipbuilding business. It operates through the following business segments: Ingalls, Newport News, and Mission Technologies. The Ingalls segment designs and constructs non-nuclear ships, including amphibious assault ships, expeditionary warfare ships, surface combatants, and national security cutters (NSC). The Newport News segment designs and builds nuclear-powered aircraft carriers and submarines, and the refueling and overhaul and the inactivation of nuclear-powered aircraft carriers. The Mission Technologies segment includes business groups focused on high-end information technology (IT) and mission-based solutions for DoD, intelligence, and federal civilian customers, life-cycle sustainment services to the U.S. Navy fleet and other maritime customers, unmanned, autonomous systems, and nuclear management and operations and environmental management services for the Department of Energy (DoE), DoD, state and local governments, and private sector companies. The company was founded on August 4, 2010 and is headquartered in Newport News, VA.

Huntington Ingalls Industries Inc

Huntington Ingalls is trending amid discussions about the potential for increased shipbuilding as a countermeasure to China's growing naval power, as well as a possible Merchant Marine fleet expansion. Community members are also weighing the company's strong market position against its current valuation, noting that while it's a solid company, the present price might not be attractive for new investors. Some traders are eyeing potential Korean and Japanese partnerships.

MaxsMaking, Inc. is a holding company, which engages in the manufacture of customized consumer goods. It offers a range of customizable textile products, including backpacks, thermal bags, canvas bags, aprons, throw pillows, flags, and advertising chair covers. The company was founded by Xiao Zhong Lin and Xue Fen Zhang in January 2007 and is headquartered in Shanghai, China.

MaxsMaking Inc. - Ordinary Shares - Class A

MaxsMaking Inc. Class A Ordinary Shares

MaxsMaking (MAMK) is trending due to discussions around its low float and potential for volatility, with some traders comparing it to other recent runners. Community members are actively discussing trading strategies, potential price movements, and halt patterns, while also noting the company's business in textiles manufacturing.

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Holdings Ord Shs

Karman Holdings is trending as investors discuss its potential in the defense sector, particularly its missile systems, with some viewing it as a hidden gem. Community members are also highlighting the company's upcoming earnings report and analysts' positive ratings, with some projecting significant upside potential. The stock's performance since its IPO and potential benefits from increased missile demand are also driving interest.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as traders discuss its potential breakout and decoupling from Bitcoin, despite some scheduled maintenance outages on major exchanges. Community members are pointing to positive news, potential ETF approvals, and increasing institutional interest as possible catalysts. However, some remain skeptical, citing historical price patterns and the ongoing government shutdown as potential headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE.</li><li>The partnership aims to advance an off-the-shelf LVV Plasmid DNA platform to improve gene therapy production.</li><li>Genenta Science is a clinical-stage biotech company focused on developing immuno-oncology therapies.</li></ul>Genenta Science (GNTA) stock is set to hit an all-time high on Friday after the company announced that it has joined forces with biotech manufacturing organization ANEMOCYTE to develop tools for gene and cell therapy.&nbsp;At&nbsp;the time of writing&nbsp;<a href="https://stocktwits.com/symbol/GNTA">Genenta Science stock</a> traded over 300% higher in Friday’s premarket. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ territory the previous day. Message volume improved to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;The collaboration centers on developing an off-the-shelf lentiviral vector (LVV) Plasmid DNA technology platform to boost the production of high-quality genetic materials used in advanced therapies.<h2 class="st-heading-2">Expanded Partnership</h2>The new strategic agreement strengthens an already productive relationship between the two firms, previously focused on Plasmid DNA manufacturing.&nbsp;The companies intend to combine Genenta’s experience with LVV Plasmid DNA technology, originally derived from the research of co-founder Professor Luigi Naldini, with ANEMOCYTE’s production capabilities to deliver dependable materials for research and clinical applications.What Is Genenta Science Known For?&nbsp;Genenta Science is a clinical-stage biotech company focused on developing immuno-oncology therapies that harness hematopoietic stem cells to fight tumor cancers. Its lead candidate, Temferon, is engineered to deliver immune-activating payloads directly within the tumor microenvironment through modified bone marrow-derived cells, aiming for a precise and lasting anti-cancer effect.<blockquote>“By making our clinically validated LVV Plasmid DNA technology platform available to ANEMOCYTE and its clients, we are contributing to the reliable and scalable development of advanced therapy programs across the industry.”-Pierluigi Paracchi, CEO, Genenta Science.</blockquote>Genenta Science's stock has lost over 25% in 2025 and over 39% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/alphabet-apple-meta-lead-private-funding-for-trump-s-white-house-ballroom/cLGJQyRR3s4">Alphabet, Apple, Meta Lead Private Funding For Trump’s ‘Big, Beautiful’ $250M White House Ballroom Project, Donor List Reveals</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A piece of a plasmid model is stained at Biontech's Goerzhausen I site.

GNTA Stock Skyrockets 300% Pre-Market Toward Record Highs: What’s Driving The Super Rally?

Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE.

Equity

TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT 'ITALY ON THE MOVE 2025' SIDE EVENT DURING J.P. MORGAN HEALTHCARE...

ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE

ITALIAN TRADE AGENCY TO HOST 'ITALY ON THE MOVE 2025' SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE ITALIAN TRADE AGENCY TO HOST 'ITALY ON THE MOVE 2025' SIDE EVENT DURING J.P. MORGAN...

Genenta Science's Loyalty Shares: A Double-Edged Sword for ADS Liquidity and Investor Influence?

Genenta Science SpA Sponsored ADR (GNTA) has disclosed a new risk, in the Share Price & Shareholder Rights category. Genenta Science's proposed loy...

Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors

Based on Preliminary Data from Ongoing Dose Ranging Stage of the Phase 1/2 Clinical TrialMILAN, Italy and NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a...

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

GNTA
Genenta Science SpA - ADR

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest GNTA News

GNTAGenenta Science SpA - ADR